The global market for Next Generation IVD was valued at US$ 42340 million in the year 2023 and is projected to reach a revised size of US$ 77050 million by 2030, growing at a CAGR of 9.0% during the forecast period.
Next-Generation In Vitro Diagnostics (IVD) refers to advanced diagnostic tools and technologies designed to enhance the precision, speed, and accessibility of medical testing. These solutions leverage cutting-edge methodologies such as molecular diagnostics, artificial intelligence, microfluidics, and next-generation sequencing (NGS). The goal of next-gen IVDs is to enable earlier detection of diseases, personalized medicine, and better disease management, ultimately improving patient outcomes. Examples include real-time PCR, liquid biopsy platforms, and point-of-care devices that can deliver rapid, actionable results.
North American market for Next Generation IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next Generation IVD in Autoimmune Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next Generation IVD include Danaher, Roche, Abbott, ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ, Hologic, Thermo Fisher Scientific, Bio-Bio, B, Shengxiang Bio, COYOTE, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next Generation IVD, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation IVD.
The Next Generation IVD market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation IVD market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation IVD companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher
Roche
Abbott
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Hologic
Thermo Fisher Scientific
Bio-Bio
B
Shengxiang Bio
COYOTE
Hangzhou Yousida
Illumina
Eurofins Scientific
BGI
Natera
Berry Genomics
Novogene
BGI Intelligence
LabCorp
Pacific Biosciences
Azenta Life Sciences
Oxford Nanopore
Macrogen
Segment by Type
Consumables
Instruments
Segment by Application
Autoimmune Diseases
Cardiology
Diabetes
Infectious Diseases
Nephrology
Oncology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation IVD company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation IVD Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Next Generation IVD Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Autoimmune Diseases
1.3.3 Cardiology
1.3.4 Diabetes
1.3.5 Infectious Diseases
1.3.6 Nephrology
1.3.7 Oncology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation IVD Market Perspective (2019-2030)
2.2 Global Next Generation IVD Growth Trends by Region
2.2.1 Global Next Generation IVD Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation IVD Historic Market Size by Region (2019-2024)
2.2.3 Next Generation IVD Forecasted Market Size by Region (2025-2030)
2.3 Next Generation IVD Market Dynamics
2.3.1 Next Generation IVD Industry Trends
2.3.2 Next Generation IVD Market Drivers
2.3.3 Next Generation IVD Market Challenges
2.3.4 Next Generation IVD Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation IVD Players by Revenue
3.1.1 Global Top Next Generation IVD Players by Revenue (2019-2024)
3.1.2 Global Next Generation IVD Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation IVD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Next Generation IVD Revenue
3.4 Global Next Generation IVD Market Concentration Ratio
3.4.1 Global Next Generation IVD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation IVD Revenue in 2023
3.5 Global Key Players of Next Generation IVD Head office and Area Served
3.6 Global Key Players of Next Generation IVD, Product and Application
3.7 Global Key Players of Next Generation IVD, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation IVD Breakdown Data by Type
4.1 Global Next Generation IVD Historic Market Size by Type (2019-2024)
4.2 Global Next Generation IVD Forecasted Market Size by Type (2025-2030)
5 Next Generation IVD Breakdown Data by Application
5.1 Global Next Generation IVD Historic Market Size by Application (2019-2024)
5.2 Global Next Generation IVD Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation IVD Market Size (2019-2030)
6.2 North America Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation IVD Market Size by Country (2019-2024)
6.4 North America Next Generation IVD Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation IVD Market Size (2019-2030)
7.2 Europe Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation IVD Market Size by Country (2019-2024)
7.4 Europe Next Generation IVD Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation IVD Market Size (2019-2030)
8.2 Asia-Pacific Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation IVD Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation IVD Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation IVD Market Size (2019-2030)
9.2 Latin America Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation IVD Market Size by Country (2019-2024)
9.4 Latin America Next Generation IVD Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation IVD Market Size (2019-2030)
10.2 Middle East & Africa Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation IVD Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation IVD Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Next Generation IVD Introduction
11.1.4 Danaher Revenue in Next Generation IVD Business (2019-2024)
11.1.5 Danaher Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Next Generation IVD Introduction
11.2.4 Roche Revenue in Next Generation IVD Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Next Generation IVD Introduction
11.3.4 Abbott Revenue in Next Generation IVD Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
11.4.1 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Company Details
11.4.2 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Business Overview
11.4.3 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Next Generation IVD Introduction
11.4.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Revenue in Next Generation IVD Business (2019-2024)
11.4.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Next Generation IVD Introduction
11.5.4 Hologic Revenue in Next Generation IVD Business (2019-2024)
11.5.5 Hologic Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Next Generation IVD Introduction
11.6.4 Thermo Fisher Scientific Revenue in Next Generation IVD Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Bio-Bio
11.7.1 Bio-Bio Company Details
11.7.2 Bio-Bio Business Overview
11.7.3 Bio-Bio Next Generation IVD Introduction
11.7.4 Bio-Bio Revenue in Next Generation IVD Business (2019-2024)
11.7.5 Bio-Bio Recent Development
11.8 B
11.8.1 B Company Details
11.8.2 B Business Overview
11.8.3 B Next Generation IVD Introduction
11.8.4 B Revenue in Next Generation IVD Business (2019-2024)
11.8.5 B Recent Development
11.9 Shengxiang Bio
11.9.1 Shengxiang Bio Company Details
11.9.2 Shengxiang Bio Business Overview
11.9.3 Shengxiang Bio Next Generation IVD Introduction
11.9.4 Shengxiang Bio Revenue in Next Generation IVD Business (2019-2024)
11.9.5 Shengxiang Bio Recent Development
11.10 COYOTE
11.10.1 COYOTE Company Details
11.10.2 COYOTE Business Overview
11.10.3 COYOTE Next Generation IVD Introduction
11.10.4 COYOTE Revenue in Next Generation IVD Business (2019-2024)
11.10.5 COYOTE Recent Development
11.11 Hangzhou Yousida
11.11.1 Hangzhou Yousida Company Details
11.11.2 Hangzhou Yousida Business Overview
11.11.3 Hangzhou Yousida Next Generation IVD Introduction
11.11.4 Hangzhou Yousida Revenue in Next Generation IVD Business (2019-2024)
11.11.5 Hangzhou Yousida Recent Development
11.12 Illumina
11.12.1 Illumina Company Details
11.12.2 Illumina Business Overview
11.12.3 Illumina Next Generation IVD Introduction
11.12.4 Illumina Revenue in Next Generation IVD Business (2019-2024)
11.12.5 Illumina Recent Development
11.13 Eurofins Scientific
11.13.1 Eurofins Scientific Company Details
11.13.2 Eurofins Scientific Business Overview
11.13.3 Eurofins Scientific Next Generation IVD Introduction
11.13.4 Eurofins Scientific Revenue in Next Generation IVD Business (2019-2024)
11.13.5 Eurofins Scientific Recent Development
11.14 BGI
11.14.1 BGI Company Details
11.14.2 BGI Business Overview
11.14.3 BGI Next Generation IVD Introduction
11.14.4 BGI Revenue in Next Generation IVD Business (2019-2024)
11.14.5 BGI Recent Development
11.15 Natera
11.15.1 Natera Company Details
11.15.2 Natera Business Overview
11.15.3 Natera Next Generation IVD Introduction
11.15.4 Natera Revenue in Next Generation IVD Business (2019-2024)
11.15.5 Natera Recent Development
11.16 Berry Genomics
11.16.1 Berry Genomics Company Details
11.16.2 Berry Genomics Business Overview
11.16.3 Berry Genomics Next Generation IVD Introduction
11.16.4 Berry Genomics Revenue in Next Generation IVD Business (2019-2024)
11.16.5 Berry Genomics Recent Development
11.17 Novogene
11.17.1 Novogene Company Details
11.17.2 Novogene Business Overview
11.17.3 Novogene Next Generation IVD Introduction
11.17.4 Novogene Revenue in Next Generation IVD Business (2019-2024)
11.17.5 Novogene Recent Development
11.18 BGI Intelligence
11.18.1 BGI Intelligence Company Details
11.18.2 BGI Intelligence Business Overview
11.18.3 BGI Intelligence Next Generation IVD Introduction
11.18.4 BGI Intelligence Revenue in Next Generation IVD Business (2019-2024)
11.18.5 BGI Intelligence Recent Development
11.19 LabCorp
11.19.1 LabCorp Company Details
11.19.2 LabCorp Business Overview
11.19.3 LabCorp Next Generation IVD Introduction
11.19.4 LabCorp Revenue in Next Generation IVD Business (2019-2024)
11.19.5 LabCorp Recent Development
11.20 Pacific Biosciences
11.20.1 Pacific Biosciences Company Details
11.20.2 Pacific Biosciences Business Overview
11.20.3 Pacific Biosciences Next Generation IVD Introduction
11.20.4 Pacific Biosciences Revenue in Next Generation IVD Business (2019-2024)
11.20.5 Pacific Biosciences Recent Development
11.21 Azenta Life Sciences
11.21.1 Azenta Life Sciences Company Details
11.21.2 Azenta Life Sciences Business Overview
11.21.3 Azenta Life Sciences Next Generation IVD Introduction
11.21.4 Azenta Life Sciences Revenue in Next Generation IVD Business (2019-2024)
11.21.5 Azenta Life Sciences Recent Development
11.22 Oxford Nanopore
11.22.1 Oxford Nanopore Company Details
11.22.2 Oxford Nanopore Business Overview
11.22.3 Oxford Nanopore Next Generation IVD Introduction
11.22.4 Oxford Nanopore Revenue in Next Generation IVD Business (2019-2024)
11.22.5 Oxford Nanopore Recent Development
11.23 Macrogen
11.23.1 Macrogen Company Details
11.23.2 Macrogen Business Overview
11.23.3 Macrogen Next Generation IVD Introduction
11.23.4 Macrogen Revenue in Next Generation IVD Business (2019-2024)
11.23.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Danaher
Roche
Abbott
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Hologic
Thermo Fisher Scientific
Bio-Bio
B
Shengxiang Bio
COYOTE
Hangzhou Yousida
Illumina
Eurofins Scientific
BGI
Natera
Berry Genomics
Novogene
BGI Intelligence
LabCorp
Pacific Biosciences
Azenta Life Sciences
Oxford Nanopore
Macrogen
Ìý
Ìý
*If Applicable.
